Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
4.110
-0.030 (-0.72%)
At close: Nov 18, 2025, 4:00 PM EST
4.110
0.00 (0.00%)
After-hours: Nov 18, 2025, 4:00 PM EST
Cellectis Employees
As of December 31, 2024, Cellectis had 222 total employees, including 216 full-time and 6 part-time employees. The number of employees increased by 1 or 0.45% compared to the previous year.
Employees
222
Change (1Y)
1
Growth (1Y)
0.45%
Revenue / Employee
$371,851
Profits / Employee
-$159,248
Market Cap
309.95M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 222 | 1 | 0.45% |
| Dec 31, 2023 | 221 | -16 | -6.75% |
| Dec 31, 2022 | 237 | -63 | -21.00% |
| Dec 31, 2021 | 300 | 19 | 6.76% |
| Dec 31, 2020 | 281 | 17 | 6.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CLLS News
- 11 days ago - Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 15 days ago - Cellectis to Present a Development Update for eti-cel at ASH 2025 - GlobeNewsWire
- 18 days ago - Cellectis to Report Third Quarter Financial Results on November 7, 2025 - GlobeNewsWire
- 4 weeks ago - Cellectis' R&D Day Highlights Lasme-cel's Potential to Address Significant Unmet Need for Patients with r/r B-ALL - GlobeNewsWire
- 4 weeks ago - Top 2 Health Care Stocks That May Keep You Up At Night This Month - Benzinga
- 4 weeks ago - Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers - GlobeNewsWire
- 6 weeks ago - Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress - GlobeNewsWire
- 3 months ago - Cellectis S.A. (CLLS) Q2 2025 Earnings Call Transcript - Seeking Alpha